$993 Million is the total value of Bronte Capital Management Pty Ltd.'s 28 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
GOOGL | ALPHABET INCcap stk cl a | $142,955,521 | +9.3% | 1,092,431 | 0.0% | 14.40% | +14.2% | |
BATH & BODY WORKS INC | $6,442,855 | -9.9% | 190,617 | 0.0% | 0.65% | -5.9% | ||
BNTX | BIONTECH SEsponsored ads | $2,552,931 | +0.7% | 23,499 | 0.0% | 0.26% | +4.9% | |
RISKIFIED LTD | $2,298,710 | -7.8% | 513,105 | 0.0% | 0.23% | -3.7% | ||
CTMX | CYTOMX THERAPEUTICS INC | $1,193,566 | -25.0% | 925,245 | 0.0% | 0.12% | -22.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-06
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
CORTEVA NC | 17 | Q3 2023 | 6.2% |
GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
SCHEDULE 13G | 2024-02-13 |
13F-HR | 2024-02-07 |
13F-HR | 2023-11-06 |
13F-HR | 2023-08-08 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-03 |
13F-HR/A | 2022-08-08 |
13F-HR | 2022-08-08 |
13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.